Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

Jan. 21, 2022

Researchers suggest ZEB2 targeting as an approach for atherosclerosis

Jan. 18, 2022

Targeting GNAO1 presents a new therapeutic strategy for heart failure

Jan. 13, 2022

VCAM-1-targeting polyelectrolyte complex enhances therapeutic efficacy of miR-92a inhibitors in vivo

Jan. 12, 2022

DiNAQOR and CMRI enter research collaboration on cardiac specific AAV capsids

Jan. 11, 2022

Tenaya expands heart disease pipeline with selection of TN-401 as development candidate

Jan. 11, 2022

MCUF-651, a GC-A PAM for the treatment of cardiovascular, renal and metabolic diseases

Jan. 5, 2022

Cardiovascular

Jan. 1, 2022

Researchers discover more than 1,300 genes linked to congenital heart disease

Dec. 20, 2021

Newly identified variant has large effects on two aspects of cardiovascular risk

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.